Literature DB >> 1511845

Endothelium-dependent vasodilation by LP-805, a novel vasodilating agent, on rat thoracic aorta.

K Kishii1, T Morimoto, N Nakajima, M Tsujitani, I Takayanagi.   

Abstract

1. In rat aortae with [E(+)-tissue] and without [E(-)-tissue] intact endothelium, LP-805 relaxed the preparations precontracted with 35.9 mM K+ and its action in E(+)-tissues was more potent than that in E(-)-tissues. Moreover, the inhibitory action of glibenclamide in E(-)-tissues was more potent than that in E(+)-tissues. 2. The relaxing action of LP-805 on E(+)-tissues treated with NG-nitro-L-arginine methyl ester (10 microM), a potent inhibitor of nitric oxide synthesis, was the same as that in E(-)-tissues. 3. Methylene blue (10 microM) also inhibited the LP-805 induced relaxation in E(+)-tissues. 4. Indomethacin (10 microM) had no effect on LP-805-induced relaxation in E(+)-tissues. 5. These results suggest that the vasorelaxant action of LP-805 involves the mechanism which causes the release of nitric oxide (NO) from vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511845     DOI: 10.1016/0306-3623(92)90093-y

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

1.  The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.

Authors:  M Ushio-Fukai; K Hirano; H Kanaide
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

2.  A target K+ channel for the LP-805-induced hyperpolarization in smooth muscle cells of the rabbit portal vein.

Authors:  M Kamouchi; S Kajioka; T Sakai; K Kitamura; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.